About SentiAR
SentiAR is a company based in St. Louis (United States) founded in 2017 by Michael Southworth. SentiAR has raised $28.25 million across 11 funding rounds from investors including NIH, HHS and Arch Grants. The company has 8 employees as of December 31, 2022. SentiAR offers products and services including CommandEP. SentiAR operates in a competitive market with competitors including Augmedics, Biomodex, eCential Robotics, Enhatch and Proximie, among others.
- Headquarter St. Louis, United States
- Employees 8 as on 31 Dec, 2022
- Founders Michael Southworth
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sentiar, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28.25 M (USD)
in 11 rounds
-
Latest Funding Round
$1.49 M (USD), Series B
Apr 30, 2026
-
Investors
NIH
& 14 more
-
Employee Count
8
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SentiAR
SentiAR offers a comprehensive portfolio of products and services, including CommandEP.
Creates interactive 3D visuals for heart procedures using real-time data.
People of SentiAR
Unlock access to complete
Software Development Team
3 people
Leadership Team
1 people
Co Team
1 people
Principal Team
1 people
Unlock access to complete
Funding Insights of SentiAR
SentiAR has successfully raised a total of $28.25M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $1.49 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SentiAR
SentiAR has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and Arch Grants.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
MedVenture Partners is focused on medical device venture investments.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital investment opportunities are provided for accredited investors.
|
Locked | Locked | Locked |
Investor details for SentiAR
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SentiAR
Investment portfolio details for SentiAR
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SentiAR
Detailed financials for SentiAR
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sentiar Comparisons
Peer comparison for SentiAR
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SentiAR
SentiAR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmedics, Biomodex, eCential Robotics, Enhatch and Proximie, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Augmented reality systems for guiding surgical procedures are developed.
|
|
| Locked | Locked | Locked |
3D printed surgical simulators for medical education and patient-specific preoperative planning
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
Provider of mobile enterprise apps for Salesforce
|
|
| Locked | Locked | Locked |
Provider of a cloud-based VR platform for surgery guidance
|
Detailed competitors of SentiAR
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sentiar
Complete news archive for SentiAR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SentiAR
SentiAR was founded in 2017.
SentiAR is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Berk Tas is the current CEO of SentiAR.
SentiAR is a funded company, having raised a total of $28.25M across 11 funding rounds to date.
As of Dec 31, 2022, the latest employee count at SentiAR is 8.
Founded in 2017 and based in St. Louis, United States, SentiAR operates in the medical technology sector. A 3D visualization platform is developed for interventional cardiac procedures, utilizing a head-up display. Anatomic models are made visible to clinicians, supporting procedures that require precision. Leadership includes co-founder Michael Southworth and CEO Berk Tas. The platform is accessible via sentiar.com.
SentiAR's top competitors include Augmedics, eCential Robotics and LensAR.
SentiAR offers CommandEP.
SentiAR has 15 investors. Key investors include NIH, HHS, Arch Grants, Keiretsu Forum, and MedVenture Partners.